Related Experiment Video
Updated: Aug 22, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD)
Damiano Rizzoni1,2, Claudia Agabiti-Rosei3,4, Carolina De Ciuceis3,4
1Chair of Internal Medicine, Department of Clinical and Experimental Sciences, University of Brescia, c/o 2a Medicina Spedali Civili di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy. damiano.rizzoni@unibs.it.
Insights
Coronary artery calcium score (CACS) shows promise for cardiovascular risk stratification, especially in intermediate-risk patients. However, its role in routine hypertension management and early detection of hypertension-mediated organ damage remains controversial due to insufficient evidence.
Area of Science:
- Cardiovascular Medicine
- Radiology
- Preventive Cardiology
Background:
- Calcium plays a crucial role in vascular wall functions, including endothelial permeability and smooth muscle cell activity.
- Coronary artery calcification (CAC) reflects these calcium-dependent processes within the vessel wall.
Purpose of the Study:
- To evaluate the utility of coronary artery calcium score (CACS) in cardiovascular risk stratification.
- To assess the current guidelines' recommendations regarding CACS in hypertension management and early detection of hypertension-mediated organ damage (HMOD).
Main Methods:
- Review of current guidelines and evidence regarding the use of CACS in cardiovascular risk assessment.
- Analysis of CACS's prognostic value in various populations, including hypertensive patients.
Main Results:
- CACS demonstrates prognostic value and usefulness in cardiovascular risk stratification, particularly in high-risk populations and hypertensive patients.
- Current hypertension management guidelines do not widely recommend CACS for early HMOD detection.
- Some cardiology guidelines suggest CACS may aid risk classification, especially around treatment thresholds, but its use remains debated.
Conclusions:
- The diagnostic utility of CACS is currently debated.
- Evidence supports CACS for improving cardiovascular risk stratification in primary prevention, especially for intermediate-risk individuals.
- Insufficient evidence exists to support CACS as a standard tool for assessing HMOD.
Abstract:
Calcium controls numerous events within the vessel wall. Permeability of the endothelium is calcium dependent, as are platelet activation and adhesion, vascular smooth muscle proliferation and migration, and synthesis of fibrous connective tissue. Double-helix computerized tomography is a noninvasive technique that can detect, measure, and compare coronary calcification in the coronary arteries. Despite some convincing evidence about the prognostic value and usefulness of coronary artery calcium score (CACS) in the stratification of cardiovascular risk in the high risk general population and also in hypertensive patients, current guidelines for the management of hypertension, do not include such evaluation among the recommended procedures to be performed in the majority of patients even with the intent to detect hypertension-mediated organ damage (HMOD) in an early phase. On the contrary, the European Society of Cardiology guidelines for the diagnosis and management of chronic coronary syndromes, the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, and the 2018 Cholesterol Clinical Practice Guidelines indicate that the evaluation of CACS may be of some usefulness in specific subpopulations, although this view is not accepted in the US Preventive Services Task Force document. Very recently, the European Society of Cardiology Guidelines on cardiovascular disease prevention in clinical practice stated that CACS estimation may be considered to improve risk classification around treatment decision thresholds. In conclusion, the use of CACS as a diagnostic tool is still controversial. While some evidence exists about is ability to improve stratification of cardiovascular risk in primary prevention, in particular in selected patients who are at intermediate or borderline risk of atherosclerotic cardiovascular disease, there is insufficient evidence to use it as a standard means to assess HMOD.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Coronary Artery Disease I: Introduction

